PAR HEALTH

Live / Allowed — Published for opposition (as of 10 Mar 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Sept 2025 filing date already counts against anyone who files later.

Record

Serial number
99409684
Mark type
Word mark
Filed
24 Sept 2025
Published for opposition
10 Mar 2026
Attorney of record
Camille M. Miller

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; Pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatrics, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents
  • Class 035 — Advertising and business services: Outsourcing services in the nature of arranging procurement of goods for others in the field of pharmaceuticals; Business administration of patient reimbursement programs for pharmaceuticals; Business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient
  • Class 040 — Treatment of materials: Custom manufacture of pharmaceutical products to the order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
  • Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services
  • Class 044 — Medical, beauty and agricultural services: Charitable Services, namely patient assistance programs that provide pharmaceuticals to help patients with low income get pharmaceuticals at little or no cost to the patient

Owner

Prior registrations

Prosecution history

  • 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 10 Mar 2026 — PUBLISHED FOR OPPOSITION
  • 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 17 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 17 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
  • 17 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 17 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
  • 17 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
  • 17 Feb 2026 — ASSIGNED TO EXAMINER
  • 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 24 Sept 2025 — APPLICATION FILING RECEIPT MAILED
  • 24 Sept 2025 — NEW APPLICATION ENTERED

View this trademark record on Marksy